{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T04:01:17Z","timestamp":1789704077906,"version":"4.0.1"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Joint Fund Project of Natural Science Foundation of Hubei Province","award":["2023AFD172"],"award-info":[{"award-number":["2023AFD172"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-025-04139-7","type":"journal-article","created":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T10:59:19Z","timestamp":1745578759000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Celastrol modulates damage of renal tissues in Immunoglobulin A nephropathy via targeting TGase-2\/HMGB1 signaling pathway"],"prefix":"10.1186","volume":"26","author":[{"given":"Yanping","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruman","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danfang","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,25]]},"reference":[{"issue":"1","key":"4139_CR1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1159\/000484717","volume":"4","author":"JH Hou","year":"2018","unstructured":"Hou JH, Zhu HX, Zhou ML, Le WB, Zeng CH, Liang SS, Xu F, Liang DD, Shao SJ, Liu Y, Liu ZH. Changes in the spectrum of kidney diseases: an analysis of 40,759 Biopsy-Proven cases from 2003 to 2014 in China. Kidney Dis (Basel). 2018;4(1):10\u20139.","journal-title":"Kidney Dis (Basel)"},{"issue":"4","key":"4139_CR2","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s40620-016-0299-0","volume":"29","author":"D Maixnerova","year":"2016","unstructured":"Maixnerova D, Reily C, Bian Q, Neprasova M, Novak J, Tesar V. Markers for the progression of IgA nephropathy. J Nephrol. 2016;29(4):535\u201341.","journal-title":"J Nephrol"},{"issue":"17","key":"4139_CR3","first-page":"2048","volume":"122","author":"XQ Yu","year":"2009","unstructured":"Yu XQ, Wei JL. Kidney disease in China: recent progress and prospects. Chin Med J (Engl). 2009;122(17):2048\u201353.","journal-title":"Chin Med J (Engl)"},{"issue":"2","key":"4139_CR4","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.amjms.2020.10.003","volume":"361","author":"A Rajasekaran","year":"2021","unstructured":"Rajasekaran A, Julian BA, Rizk DV. IgA nephropathy: an interesting autoimmune kidney disease. Am J Med Sci. 2021;361(2):176\u201394.","journal-title":"Am J Med Sci"},{"issue":"3","key":"4139_CR5","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.jep.2011.12.009","volume":"139","author":"YJ Wang","year":"2012","unstructured":"Wang YJ, He LQ, Sun W, Lu Y, Wang XQ, Zhang PQ, Wei LB, Cao SL, Yang NZ, Ma HZ, Gao J, Li P, Tao XJ, Yuan FH, Li J, Yao C, Liu X. Optimized project of traditional Chinese medicine in treating chronic kidney disease stage 3: a multicenter double-blinded randomized controlled trial. J Ethnopharmacol. 2012;139(3):757\u201364.","journal-title":"J Ethnopharmacol"},{"issue":"3","key":"4139_CR6","doi-asserted-by":"publisher","first-page":"c194","DOI":"10.1159\/000118942","volume":"108","author":"F Sato","year":"2008","unstructured":"Sato F, Maruyama S, Hayashi H, Sakamoto I, Yamada S, Uchimura T, Morita Y, Ito Y, Yuzawa Y, Maruyama I, Matsuo S. High mobility group box chromosomal protein 1 in patients with renal diseases. Nephron Clin Pract. 2008;108(3):c194\u2013201.","journal-title":"Nephron Clin Pract"},{"issue":"22","key":"4139_CR7","doi-asserted-by":"publisher","first-page":"8394","DOI":"10.1074\/jbc.RA117.001078","volume":"293","author":"WL Willis","year":"2018","unstructured":"Willis WL, Wang L, Wada TT, Gardner M, Abdouni O, Hampton J, Valiente G, Young N, Ardoin S, Agarwal S, Freitas MA, Wu LC, Jarjour WN. The Proinflammatory protein HMGB1 is a substrate of transglutaminase-2 and forms high-molecular weight complexes with autoantigens. J Biol Chem. 2018;293(22):8394\u2013409.","journal-title":"J Biol Chem"},{"key":"4139_CR8","doi-asserted-by":"publisher","first-page":"794962","DOI":"10.3389\/fmed.2021.794962","volume":"8","author":"M Xia","year":"2021","unstructured":"Xia M, Liu D, Liu H, et al. Based on network pharmacology tools to investigate the mechanism of tripterygium wilfordii against IgA nephropathy. Front Med (Lausanne). 2021;8:794962.","journal-title":"Front Med (Lausanne)"},{"issue":"10","key":"4139_CR9","first-page":"1093","volume":"36","author":"M Takahashi-Kobayashi","year":"2021","unstructured":"Takahashi-Kobayashi M, Usui J, Yaguchi M, et al. Immunohistological score of transcription factor 21 had a positive correlation with its urinary excretion and proteinuria in immunoglobulin A nephropathy. Histol Histopathol. 2021;36(10):1093\u20138.","journal-title":"Histol Histopathol"},{"key":"4139_CR10","doi-asserted-by":"publisher","unstructured":"Schena FP, Cox SN. Biomarkers and precision medicine in IgA nephropathy. Semin Nephrol. 2018;38(5):521\u2013530. https:\/\/doi.org\/10.1016\/j.semnephrol.2018.05.022. PMID: 30177024.","DOI":"10.1016\/j.semnephrol.2018.05.022"},{"issue":"1","key":"4139_CR11","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s40620-015-0246-5","volume":"29","author":"SM Lechner","year":"2016","unstructured":"Lechner SM, Papista C, Chemouny JM, Berthelot L, Monteiro RC. Role of IgA receptors in the pathogenesis of IgA nephropathy. J Nephrol. 2016;29(1):5\u201311. Epub 2015 Nov 14. PMID: 26572664.","journal-title":"J Nephrol"},{"key":"4139_CR12","doi-asserted-by":"crossref","unstructured":"Huawei Lv, Liangping Jiang, Mengdi Zhu, Yuxia Li, Meng Luo, Peiheng Jiang, Shengqiang Tong, Hongjian Zhang, Jizhong Yan. The genus Tripterygium: A phytochemistry and pharmacological review. Fitoterapia. 2019;137.","DOI":"10.1016\/j.fitote.2019.104190"},{"key":"4139_CR13","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.ebiom.2018.09.031","volume":"36","author":"X Yu","year":"2018","unstructured":"Yu X, Meng X, Xu M, et al. Celastrol ameliorates cisplatin nephrotoxicity by inhibiting NF-\u03baB and improving mitochondrial function. EBioMedicine. 2018;36:266\u201380.","journal-title":"EBioMedicine"},{"key":"4139_CR14","doi-asserted-by":"publisher","first-page":"887","DOI":"10.2147\/DDDT.S402503","volume":"17","author":"J Zhao","year":"2023","unstructured":"Zhao J, Liu H, Xia M, et al. Network pharmacology and experimental validation to explore that celastrol targeting PTEN is the potential mechanism of tripterygium wilfordii (L\u00e9v.) Hutch against IgA nephropathy. Drug Des Devel Ther. 2023;17:887\u2013900.","journal-title":"Drug Des Devel Ther"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04139-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-025-04139-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04139-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T10:59:22Z","timestamp":1745578762000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-025-04139-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,25]]},"references-count":14,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4139"],"URL":"https:\/\/doi.org\/10.1186\/s12882-025-04139-7","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,25]]},"assertion":[{"value":"27 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experimental procedures involving animals were approved by the Laboratory Animal and Ethics Committee of Hubei University of Chinese Medicine (Animal Ethics approval number: HUCMS202204005). Animal handling and experimentation strictly adhered to the regulations for the Management of Experimental Animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"209"}}